FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy

• Devy Deliyanti,

  Affiliation Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia, 3004

  ⨯
• Yuan Zhang,

  Affiliation Department of Medicine, St Vincent’s Hospital, The University of Melbourne, Fitzroy, Victoria, Australia, 3065

  ⨯
• Fay Khong,

  Affiliation Department of Medicine, St Vincent’s Hospital, The University of Melbourne, Fitzroy, Victoria, Australia, 3065

  ⨯
• David R. Berka,

  Affiliation Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia, 3004

  ⨯
• David I. Stapleton,

  Affiliation The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia, 3052

  ⨯
• Darren J. Kelly,

  Affiliation Department of Medicine, St Vincent’s Hospital, The University of Melbourne, Fitzroy, Victoria, Australia, 3065

  ⨯
• Jennifer L. Wilkinson-Berka

  * E-mail: jennifer.wilkinson-berka@monash.edu

  Affiliation Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia, 3004

  ⨯